Coronary stenting with MGuard: from conception to human trials

Edo Kaluski; Steve Tsai; Marc Klapholz

doi:10.1016/j.carrev.2007.12.002

Coronary stenting with MGuard: from conception to human trials

Edo Kaluski, Steve Tsai, Marc Klapholz

Research output: Contribution to journal › Review article › peer-review

20 Scopus citations

Abstract

MGuard is an ultra-thin polymer sleeve attached to the external surface stents. The polymer was designed to reduce distal embolization during coronary, renal, carotid, and vein graft stenting, and to potentially serve as a platform for uniform drug delivery. This report discusses the theoretical considerations that resulted in the conception of this device, and the scientific data that support the use of the innovation. With the encouraging initial feasibility and safety data, large-scale efficacy trials are currently in progress. Future applications of this platform for the treatment of cardiovascular disorders are discussed.

Original language	English (US)
Pages (from-to)	88-94
Number of pages	7
Journal	Cardiovascular Revascularization Medicine
Volume	9
Issue number	2
DOIs	https://doi.org/10.1016/j.carrev.2007.12.002
State	Published - Apr 1 2008
Externally published	Yes

Keywords

Emboli protection device
Stent thrombosis, Restenosis

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.carrev.2007.12.002

Fingerprint Dive into the research topics of 'Coronary stenting with MGuard: from conception to human trials'. Together they form a unique fingerprint.

Cite this

@article{65de0a72c72c4cbe88154e73adadea6f,

title = "Coronary stenting with MGuard: from conception to human trials",

abstract = "MGuard is an ultra-thin polymer sleeve attached to the external surface stents. The polymer was designed to reduce distal embolization during coronary, renal, carotid, and vein graft stenting, and to potentially serve as a platform for uniform drug delivery. This report discusses the theoretical considerations that resulted in the conception of this device, and the scientific data that support the use of the innovation. With the encouraging initial feasibility and safety data, large-scale efficacy trials are currently in progress. Future applications of this platform for the treatment of cardiovascular disorders are discussed.",

keywords = "Emboli protection device, Stent thrombosis, Restenosis",

author = "Edo Kaluski and Steve Tsai and Marc Klapholz",

year = "2008",

month = apr,

day = "1",

doi = "10.1016/j.carrev.2007.12.002",

language = "English (US)",

volume = "9",

pages = "88--94",

journal = "Cardiovascular Revascularization Medicine",

issn = "1553-8389",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Coronary stenting with MGuard

T2 - from conception to human trials

AU - Kaluski, Edo

AU - Tsai, Steve

AU - Klapholz, Marc

PY - 2008/4/1

Y1 - 2008/4/1

N2 - MGuard is an ultra-thin polymer sleeve attached to the external surface stents. The polymer was designed to reduce distal embolization during coronary, renal, carotid, and vein graft stenting, and to potentially serve as a platform for uniform drug delivery. This report discusses the theoretical considerations that resulted in the conception of this device, and the scientific data that support the use of the innovation. With the encouraging initial feasibility and safety data, large-scale efficacy trials are currently in progress. Future applications of this platform for the treatment of cardiovascular disorders are discussed.

AB - MGuard is an ultra-thin polymer sleeve attached to the external surface stents. The polymer was designed to reduce distal embolization during coronary, renal, carotid, and vein graft stenting, and to potentially serve as a platform for uniform drug delivery. This report discusses the theoretical considerations that resulted in the conception of this device, and the scientific data that support the use of the innovation. With the encouraging initial feasibility and safety data, large-scale efficacy trials are currently in progress. Future applications of this platform for the treatment of cardiovascular disorders are discussed.

KW - Emboli protection device

KW - Stent thrombosis, Restenosis

UR - http://www.scopus.com/inward/record.url?scp=43349093631&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43349093631&partnerID=8YFLogxK

U2 - 10.1016/j.carrev.2007.12.002

DO - 10.1016/j.carrev.2007.12.002

M3 - Review article

C2 - 18486082

AN - SCOPUS:43349093631

VL - 9

SP - 88

EP - 94

JO - Cardiovascular Revascularization Medicine

JF - Cardiovascular Revascularization Medicine

SN - 1553-8389

IS - 2

ER -